Literature DB >> 17376407

Influence of hypoxia and ischemia preconditioning on bilirubin damage to astrocytes.

Ana S Falcão1, Rui F M Silva, Adelaide Fernandes, Maria A Brito, Dora Brites.   

Abstract

Hypoxia-ischemia in the perinatal period is a common cause of neurologic disability in children and is often associated with neonatal morbidity and mortality. Another frequent condition of the newborn is hyperbilirubinemia and it is well known that deposition of unconjugated bilirubin (UCB) in the central nervous system can damage nerve cells and cause encephalopathy. Interestingly, some studies report the onset of cerebral hypoxia-ischemia as a risk factor for UCB encephalopathy, since that condition often precedes neonatal hyperbilirubinemia. However, the cellular mechanisms triggered by hypoxia-ischemia that may enforce UCB deleterious effects are not well elucidated. Therefore, we designed this study to investigate whether hypoxia (HP) or combined oxygen-glucose deprivation (OGD) followed by reoxygenation, modifies glial cell susceptibility to UCB injury. Thus, cultured astrocytes were exposed to HP or OGD for 4 h and returned to normoxic conditions for another 12 h prior to incubation with UCB for 4 h. HP and OGD effects in UCB toxicity were compared to normoxic conditions. Our results demonstrate that HP and OGD preconditioning increase the vulnerability of glial cells to UCB damage by enhancing some of the deleterious effects of UCB, namely cell death by both apoptosis and necrosis. This preconditioning also augments the UCB-induced stimulation of an inflammatory response by an effect that involves the activation of the nuclear factor kappaB activation. These findings provide a novel basis for the increased risk of brain damage in jaundiced newborns that were previously exposed to hypoxia or ischemia during the perinatal period, namely during delivery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376407     DOI: 10.1016/j.brainres.2007.02.039

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Changes in bilirubin in infants with hypoxic-ischemic encephalopathy.

Authors:  Carlo Dani; Chiara Poggi; Claudia Fancelli; Simone Pratesi
Journal:  Eur J Pediatr       Date:  2018-09-19       Impact factor: 3.183

Review 2.  Movement disorders due to bilirubin toxicity.

Authors:  Jessica Rose; Rachel Vassar
Journal:  Semin Fetal Neonatal Med       Date:  2014-12-16       Impact factor: 3.926

Review 3.  Cerebroprotective functions of HO-2.

Authors:  Helena Parfenova; Charles W Leffler
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

4.  The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation.

Authors:  Dora Brites
Journal:  Front Pharmacol       Date:  2012-05-29       Impact factor: 5.810

5.  Umbilical cord blood acid-base analysis and the development of significant hyperbilirubinemia in near-term and term newborns: a cohort study.

Authors:  Vincenzo Zanardo; Federico de Luca; Alphonse K Simbi; Matteo Parotto; Pietro Guerrini; Gianluca Straface
Journal:  Ital J Pediatr       Date:  2017-08-04       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.